Research and innovation news

Dr Sebastien Viatte spoke at the European League Against Rheumatism Congress 2014 press conference about his latest research into genotyping and arthritis.

Involvement from patients in priority setting around rheumatology research is vital. However, to date little work has been done to understand younger patients’ views.

It is well known that circadian clock dysfunction contributes to the incidence and severity of many diseases, including inflammation and metabolic syndrome.

Four year old Joe Hiller, who has a rare inherited disease, has become the first person in the world to participate in a new trial which could alter the lives of fellow sufferers.

David Ray, Professor of Medicine and Endocrinology and Consultant at Manchester Royal Infirmary, was one of a number of researchers feature in a BBC special about the circadian rhythm.

The first and only treatment designed for children and adults with the rare genetic condition, Morquio A syndrome, has now been approved for use in the European Union.

A Manchester researcher has received £1.14 million to develop pioneering new methods to identify those at risk of stillbirth, a devastating tragedy which sees approximately 4,000 babies stillborn ever